BackIntegrated BioPharma Overview

Integrated BioPharma Current Assets

Integrated BioPharma's current assets is $16M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$15.98M
↓ 18.59% YoYΔ $-3.65M vs prior year quarter

Peer trimmed avg / median

Loading

Integrated BioPharma Current Assets History

Loading

Integrated BioPharma vs. peers: Current Assets Comparison

Loading

Integrated BioPharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Integrated BioPharma (INBP) FAQ

As of the most recent data (September 2026), INBP shows a current assets of $16M. That compares with $20M in the prior-year period — down 18.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INBP's current assets is now $16M (was $20M) — a 18.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Integrated BioPharma is outperforming or lagging.

Tracking INBP's current assets over time shows whether Integrated BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $20M in the prior-year period — down 18.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Integrated BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $16M) with ownership activity and broader fundamentals.

Questions & Answers